Literature DB >> 25273286

Cognitive impairments in psychotic disorders: common mechanisms and measurement.

Deanna M Barch1, Julia M Sheffield.   

Abstract

Decades of research have provided robust evidence of cognitive impairments in psychotic disorders. Individuals with schizophrenia appear to be impaired on the majority of neuropsychological tasks, leading some researchers to argue for a "generalized deficit", in which the multitude of cognitive impairments are the result of a common neurobiological source. One such common mechanism may be an inability to actively represent goal information in working memory as a means to guide behavior, with the associated neurobiological impairment being a disturbance in the function of the dorsolateral prefrontal cortex. Here, we provide a discussion of the evidence for such impairment in schizophrenia, and how it manifests in domains typically referred to as cognitive control, working memory and episodic memory. We also briefly discuss cognitive impairment in affective psychoses, reporting that the degree of impairment is worse in schizophrenia than in bipolar disorder and psychotic major depression, but the profile of impairment is similar, possibly reflecting common mechanisms at the neural level. Given the recent release of the DSM-5, we end with a brief discussion on assessing cognition in the context of diagnosis and treatment planning in psychotic disorders.
Copyright © 2014 World Psychiatric Association.

Entities:  

Keywords:  Cognitive control; DSM-5; cognitive deficits; episodic memory; generalized deficit; psychotic disorders; schizophrenia; working memory

Year:  2014        PMID: 25273286      PMCID: PMC4219054          DOI: 10.1002/wps.20145

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  140 in total

1.  Neural basis of autobiographical memory retrieval in schizophrenia.

Authors:  Christine Cuervo-Lombard; Cédric Lemogne; Fabien Gierski; Céline Béra-Potelle; Eric Tran; Christophe Portefaix; Arthur Kaladjian; Laurent Pierot; Frédéric Limosin
Journal:  Br J Psychiatry       Date:  2012-04-26       Impact factor: 9.319

Review 2.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

3.  Bilateral hippocampal dysfunction in schizophrenia.

Authors:  Faith M Hanlon; Jon M Houck; Clinton J Pyeatt; S Laura Lundy; Matthew J Euler; Michael P Weisend; Robert J Thoma; Juan R Bustillo; Gregory A Miller; Claudia D Tesche
Journal:  Neuroimage       Date:  2011-07-07       Impact factor: 6.556

4.  Brain network connectivity in individuals with schizophrenia and their siblings.

Authors:  Grega Repovs; John G Csernansky; Deanna M Barch
Journal:  Biol Psychiatry       Date:  2010-12-30       Impact factor: 13.382

5.  Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.

Authors:  Rafael Tabarés-Seisdedos; Vicente Balanzá-Martínez; José Sánchez-Moreno; Anabel Martinez-Aran; José Salazar-Fraile; Gabriel Selva-Vera; Cristina Rubio; Ignacio Mata; Manuel Gómez-Beneyto; Eduard Vieta
Journal:  J Affect Disord       Date:  2008-03-04       Impact factor: 4.839

6.  Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Authors:  S Kristian Hill; John A Sweeney; Robert M Hamer; Richard S E Keefe; Diana O Perkins; Hongbin Gu; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

7.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Authors:  Dwight Dickinson; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-08-09       Impact factor: 9.306

8.  Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

Authors:  Abraham Reichenberg; Philip D Harvey; Christopher R Bowie; Ramin Mojtabai; Jonathan Rabinowitz; Robert K Heaton; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

9.  Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: an fMRI study.

Authors:  Ralf G M Schlösser; Kathrin Koch; Gerd Wagner; Igor Nenadic; Martin Roebel; Claudia Schachtzabel; Martina Axer; Christoph Schultz; Jürgen R Reichenbach; Heinrich Sauer
Journal:  Neuropsychologia       Date:  2007-07-19       Impact factor: 3.139

Review 10.  Prefrontal activation deficits during episodic memory in schizophrenia.

Authors:  John D Ragland; Angela R Laird; Charan Ranganath; Robert S Blumenfeld; Sabina M Gonzales; David C Glahn
Journal:  Am J Psychiatry       Date:  2009-05-01       Impact factor: 18.112

View more
  52 in total

1.  Methods to identify dementia in the electronic health record: Comparing cognitive test scores with dementia algorithms.

Authors:  Barbara N Harding; James S Floyd; Jeffrey F Scherrer; Joanne Salas; John E Morley; Susan A Farr; Sascha Dublin
Journal:  Healthc (Amst)       Date:  2020-05-22

2.  Abnormal large-scale resting-state functional networks in drug-free major depressive disorder.

Authors:  Liang Luo; Huawang Wu; Jinping Xu; Fangfang Chen; Fengchun Wu; Chao Wang; Jiaojian Wang
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

3.  Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice.

Authors:  Olajide S Annafi; Oritoke M Aluko; Anthony T Eduviere; Osarume Omorogbe; Solomon Umukoro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-13       Impact factor: 3.000

4.  Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk.

Authors:  Hengyi Cao; Sarah C McEwen; Yoonho Chung; Oliver Y Chén; Carrie E Bearden; Jean Addington; Bradley Goodyear; Kristin S Cadenhead; Heline Mirzakhanian; Barbara A Cornblatt; Ricardo E Carrión; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Aysenil Belger; Larry J Seidman; Heidi Thermenos; Ming T Tsuang; Theo G M van Erp; Elaine F Walker; Stephan Hamann; Alan Anticevic; Scott W Woods; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

5.  Neurobiological commonalities and distinctions among 3 major psychiatric disorders: a graph theoretical analysis of the structural connectome

Authors:  Shuai Wang; Gaolang Gong; Suyu Zhong; Jia Duan; Zhiyang Yin; Miao Chang; Shengnan Wei; Xiaowei Jiang; Yifang Zhou; Yanqing Tang; Fei Wang
Journal:  J Psychiatry Neurosci       Date:  2020-01-01       Impact factor: 6.186

6.  Disconnection Between Amygdala and Medial Prefrontal Cortex in Psychotic Disorders.

Authors:  Prerona Mukherjee; Amri Sabharwal; Roman Kotov; Akos Szekely; Ramin Parsey; Deanna M Barch; Aprajita Mohanty
Journal:  Schizophr Bull       Date:  2016-02-23       Impact factor: 9.306

7.  Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders.

Authors:  Dominique Arion; Zhiguang Huo; John F Enwright; John P Corradi; George Tseng; David A Lewis
Journal:  Biol Psychiatry       Date:  2017-04-04       Impact factor: 13.382

8.  Activation of brainstem and midbrain nuclei during cognitive control in medicated patients with schizophrenia.

Authors:  Stefanie Köhler; Gerd Wagner; Karl-Jürgen Bär
Journal:  Hum Brain Mapp       Date:  2018-09-05       Impact factor: 5.038

9.  Differentiating between clinical and behavioral phenotypes in first-episode psychosis during maintenance of visuospatial working memory.

Authors:  Maria Jalbrzikowski; Vishnu P Murty; Patricia L Stan; Jusmita Saifullan; Daniel Simmonds; William Foran; Beatriz Luna
Journal:  Schizophr Res       Date:  2017-11-11       Impact factor: 4.939

10.  Electrophysiological evidence for detrimental impact of a reappraisal emotion regulation strategy on subsequent cognitive control in schizophrenia.

Authors:  Sara K Sullivan; Gregory P Strauss
Journal:  J Abnorm Psychol       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.